INTELLIGENT BIO SOLUTIONS IN (INBS)
US36151G6008 - Common Stock
| MRQ (2024-9-30) | 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 3.99M | 6.30M | 1.54M | 8.24M | 12.57M | |||
| Receivables | 1.23M | 978.35K | 833.00K | 2.47M | 3.21M | |||
| Inventories | 738.79K | 777.54K | 980.00K | N/A | N/A | |||
| Other Current Assets | 523.78K | 474.26K | 512.00K | 164.00K | 2.42M | |||
| Total Current Assets | 6.48M | 8.53M | 3.86M | 10.87M | 18.21M | |||
| Non-Current Assets | ||||||||
| PPE Net | 846.88K | 872.59K | 1.24M | 391.00K | N/A | |||
| Investments And Advances | N/A | N/A | N/A | N/A | 0.00 | |||
| Intangibles | 4.40M | 4.37M | 5.25M | N/A | N/A | |||
| Other Non-Current Assets | N/A | N/A | N/A | 0.00 | 504.00K | |||
| Total Non-Current Assets | 5.25M | 5.24M | 6.49M | 1.48M | 3.65M | |||
| TOTAL ASSETS | 11.73M | 13.78M | 10.36M | 12.35M | 21.86M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 499.61K | 515.28K | 353.00K | N/A | N/A | |||
| Accrued Expenses | 759.08K | 1.35M | 1.36M | 1.11M | 125.00K | |||
| Accounts Payable | 1.83M | 602.34K | 1.20M | 716.00K | 1.45M | |||
| Other Current Liabilities | 2.59M | 2.98M | 2.98M | 2.84M | 2.11M | |||
| Total Current Liabilities | 5.68M | 5.45M | 5.88M | 4.66M | 3.68M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 403.00K | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 97.84K | 144.94K | 381.00K | 1.14M | 3.17M | |||
| Total Non-Current Liabilities | -57.48K | -1.22K | 672.00K | 1.06M | 3.12M | |||
| TOTAL LIABILITIES | 5.62M | 5.45M | 6.56M | 5.73M | 6.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -54.65M | -51.96M | -41.81M | -31.18M | -22.87M | |||
| Additional Paid In Capital | 61.21M | 60.97M | 46.16M | 38.44M | 38.44M | |||
| Minority Interest | -155.33K | -146.16K | -112.00K | -79.00K | -51.00K | |||
| Common Shares | 43.78K | 34.56K | 23.00K | 149.00K | 149.00K | |||
| Treasury Stock | 0.00 | 0.00 | 0.00 | N/A | N/A | |||
| Other Shareholders' Equity | -496.26K | -712.61K | -576.00K | -788.00K | -661.00K | |||
| Shares Outstanding | 4.38M | 3.46M | 194.00K | 62.00K | 57.00K | |||
| Tangible Book Value per Share | 0.39 | 1.15 | -7.51 | 106.85 | 263.95 | |||
| Total Shareholders' Equity | 6.10M | 8.33M | 3.80M | 6.63M | 15.06M | |||
| TOTAL LIABILITIES AND EQUITY | 11.73M | 13.78M | 10.36M | 12.35M | 21.86M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | 0.11 | N/A | N/A | |||
| Current Ratio | 1.14 | 1.57 | 0.66 | 2.33 | 4.94 | |||
| Return On Assets (ROA) | -88.84% | -73.71% | -102.67% | -67.24% | -32.19% | |||
| Return On Equity (ROE) | -170.65% | -121.94% | -279.86% | -125.38% | -46.73% | |||
All data in USD , ROIC based on taxRate of 0.21